About Intressa Vascular
Intressa Vascular is a company based in Gembloux (Belgium) founded in 1998. Intressa Vascular has raised $11.82 million across 1 funding round from investors including Noshaq, Yonjin Capital and SRIW. The company has 25 employees as of December 31, 2022. Intressa Vascular offers products and services including Allay Aortic Stent. Intressa Vascular operates in a competitive market with competitors including Agiliti, eWeLL Co, Affordable Care, Tesis Labs and Althea, among others.
- Headquarter Gembloux, Belgium
- Employees 25 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Intressa Vascular
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.82 M (USD)
in 1 rounds
-
Latest Funding Round
$11.82 M (USD), Series B
Oct 25, 2022
-
Investors
Noshaq
& 4 more
-
Employee Count
25
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intressa Vascular
Intressa Vascular offers a comprehensive portfolio of products and services, including Allay Aortic Stent.
Treats Type B aortic dissections by recentralizing blood flow and preserving perfusion.
Funding Insights of Intressa Vascular
Intressa Vascular has successfully raised a total of $11.82M through 1 strategic funding round. The most recent funding activity was a Series B round of $11.82 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Intressa Vascular
Intressa Vascular has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Noshaq, Yonjin Capital and SRIW.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Noshaq is recognized as a Liège-based investment fund providing financing solutions.
|
Locked | Locked | Locked | |
|
Venture capital firm backed by Yongjin Group
|
Locked | Locked | Locked | |
|
Buyouts are pursued by SRIW as a private equity firm.
|
Locked | Locked | Locked |
Investor details for Intressa Vascular
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intressa Vascular
Investment portfolio details for Intressa Vascular
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intressa Vascular
Detailed financials for Intressa Vascular
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intressa Vascular Comparisons
Peer comparison for Intressa Vascular
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intressa Vascular
Intressa Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agiliti, eWeLL Co, Affordable Care, Tesis Labs and Althea, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical equipment management services are provided by Agiliti.
|
|
| Locked | Locked | Locked |
Provider of electronic medical record services
|
|
| Locked | Locked | Locked |
Medical equipment support services are provided nationwide.
|
|
| Locked | Locked | Locked |
Medical platform for testing and equipment supply is provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical-grade medicinal cannabis is produced, supplied, and exported.
|
|
| Locked | Locked | Locked |
Digital solutions for gynecology and fertility treatments are provided by ARCH.
|
Detailed competitors of Intressa Vascular
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intressa Vascular
Complete news archive for Intressa Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intressa Vascular
Intressa Vascular was founded in 1998 and raised its 1st funding round 24 years after it was founded.
Intressa Vascular is headquartered in Gembloux, Belgium. It is registered at Gembloux, Namur, Belgium.
Pierre Douette is the current CEO of Intressa Vascular.
Intressa Vascular is a funded company, having raised a total of $11.82M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Intressa Vascular is 25.
Intressa Vascular was established in 1998 in Gembloux, Belgium, where operations are centered in the medical sector. Endovascular treatments are delivered as minimally invasive procedures for vascular disorders. Services encompass diagnostic and therapeutic interventions for patients with circulatory issues. The company is led by CEO Pierre Douette, with activities focused on regional healthcare delivery in Europe.
Intressa Vascular's top competitors include Agiliti, TEAM Technologies and Hospithera.
Intressa Vascular offers Allay Aortic Stent.
Intressa Vascular has 5 investors. Key investors include Noshaq, Yonjin Capital, SRIW, CPH, and White Fund.